• At Last

    by Sharan Abdul-Rahman, MD
    on Aug 20th, 2015

This week Flibanserin (Addyi) was approved by the FDA, making it the first medication prescribed for decreased female libido otherwise known as female hypoactive sexual desire disorder (HSDD). 

Decreased libido has been less of an issue for men. Male sexual dysfunction has focused on erectile dysfunction. Multiple medications have been FDA approved for erectile dysfunction. Viagra, the first of such medications, was approved by the FDA in 1998.

The results with Flibanserin are not impressive. It was only tested on premenopausal women. It requires daily use. There are side effects. But it is a start. 

FDA approval of Flibanserin (Addyi) is a small step in the right direction. Female sexuality is complex. We need to continue the conversation and the research on female sexuality. 

Author Sharan Abdul-Rahman, MD

You Might Also Enjoy...

Ways to avoid vaginal dryness

POST MENOPAUSE VAGINAL DRYNESS. More common than you might think.. affecting many women who are too embarrassed to speak about it.

What’s a Phthalate?

Phthalates are endocrine disruptive chemicals. They are present in our food, our beauty, health and home products. They are ubiquitous. They can pose health risks.

Updates on Female Sexual Health

Acknowledging that there is a need for a solution is the first step in solving the problem. Female sexual health is important. The following is an update as to what is currently available and what is needed..


Recent changes at the state level are making the availability of having an abortion increasingly more difficult. Collectively, we need to consider if this makes sense for the well being of our society and not get entrenched in ideological battles.


Besides being embarrassing, excessive menstrual bleeding can lead to serious medical problems. Many women are having excessive menstrual flow and are unaware that their health issues such as fatigue, anemia are related to their heavy cycles.